TFB Advisors LLC

Position in EXEL — Exelixis, Inc.

CIK 1965201 OVERLAND PARK, KS

Position in EXEL

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$798,249

+$164,807 QoQ

Shares Held

14,671

-0.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#365

of 751 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TFB Advisors LLC holds $2,452,396 across 3 Biotechnology names. EXEL ranks #2 (32.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	21,523	$1,012,441
2	EXEL	Exelixis, Inc. This page	14,671	$798,249
3	PTGX	Protagonist Therapeutics, Inc	5,235	$641,706

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$798,249	14,671	-0.7%	Shares	Sole	2026-08-06
2026-03-31	$633,442	14,769	-12.8%	Shares	Sole	2026-04-20
2025-12-31	$742,436	16,939	+6.7%	Shares	Sole	2026-02-13
2025-09-30	$655,761	15,878	—	Shares	Sole	2025-11-04
No filing history on record for this holder in this stock.